University of California, Irvine, Verifies GATC Health’s Ability to Predict Drug Efficacy, Safety and Off-target Effects

GATC’s advanced AI platform predicts outcomes of early-stage drug candidates with true positive rate of 86% and true negative rate of 91%, potentially saving billions in lost drug development costs and significantly decreasing risk for drug R&D. IRVINE, Calif., May 16, 2024 /PRNewswire/…